DRAP ENLISTED MEDICAL DEVICE
Libatape Injection Patch (Intramuscular injection sites) is enlisted with DRAP under number MDIE-0000660 as a Class A (low risk) medical device, imported. The listed holder is Coral Pharmaceuticals. It is listed as valid until 12 Apr 2028.
Screening result
MDIE-0000660 · the class is taken from DRAP's list for this number
DRAP enlisted Class A list, 28 Aug 2025
ELI-00065
| Device | Libatape Injection Patch (Intramuscular injection sites) |
|---|---|
| Class | A |
| Listed holder | Coral Pharmaceuticals |
| Holder address | A-85, SCHMS, Karachi. |
| Manufacturing site | M/s Libatape Pharmaceutical Co., Ltd., 45, Iwano, Ueiki-machi, Kita-Ku, Kumamoto-shi, Kumamoto, 861-0136, Japan |
| Issued | 13 Apr 2023 |
| Renewal date | 12 Apr 2028 |
| Licence | ELI-00065 |
Specifications
No supplier specifications yet.
Supplier of this device? Add specifications (free during launch)
Sign in or create a free account to add specifications.
Screened 6 Oct 2026, 17:09 (Pakistan time). A screening aid, not an official DRAP verification.
More devices from this holder
Other DRAP registrations and enlistments listed for the same company.
| MDIE-0000658 | Libatape Libapital [Hemostatic Plaster for dialysis or intravenous injections sites] | Class A |
| MDIE-0000659 | Libatape Surgin Leep [Film Dressing] | Class A |
| MDIR-0001849 | Polypropylene (monofilament surgical suture) | Class C |
Corrections
Is something on this page wrong? Report a correction
Corrections are checked against the evidence before anything changes on this page.
Screen another number
Source: DRAP's published provisional lists. A screening aid, not an official DRAP verification; confirm with DRAP and the supplier's original documents.